Orthofix International | OFIX - Debt


Orthofix International reported $137.23M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 73.38M 3.35M Dec/2025
Dexcom USD 1.24B 900K Mar/2026
EDAP TMS EUR 7.55M 1.41M Sep/2025
Globus Medical USD 118.66M 687K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
J&J USD 47.93B 2.14B Dec/2025
Medtronic USD 28.07B 1.03B Dec/2025
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
Smith & Nephew USD 3.32B 334M Dec/2024
STAAR Surgical USD 38.35M 764K Dec/2025
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Teleflex USD 2.73B 43.5M Dec/2025
Veracyte USD 39.65M 799K Dec/2025
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026